Clinical trial
Convalescent Plasma in the Treatment of Covid-19
NCT04600440 is registered in ClinicalTrials.gov with Skane University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Convalescent Plasma in the Treatment of Covid-19
- Lead sponsor
- Skane University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 25, 2020
- Completion date
- February 28, 2022
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.